AMN Healthcare is the leader and innovator in total talent solutions for healthcare organizations across the nation. The Company provides access to the most comprehensive network of quality healthcare professionals through its innovative recruitment strategies and breadth of career opportunities. With insights and expertise, AMN Healthcare helps providers optimize their workforce to successfully reduce complexity, increase efficiency and improve patient outcomes. AMN total talent solutions include managed services programs, clinical and interim healthcare leaders, temporary staffing, executive search solutions, vendor management systems, recruitment process outsourcing, predictive modeling, language interpretation services, revenue cycle solutions, credentialing and other services. Clients include acute-care hospitals, community health centers and clinics, physician practice groups, retail and urgent care centers, home health facilities, schools and many other healthcare settings. AMN Healthcare is committed to fostering and maintaining a diverse team that reflects the communities we serve. Our commitment to the inclusion of many different backgrounds, experiences and perspectives enables our innovation and leadership in the healthcare services industry.
Company profile
Ticker
AMN
Exchange
Website
CEO
Susan Salka
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Advanced Medical Personnel Services, LLC • AMN Allied Services, LLC • AMN Healthcare Allied, Inc. • AMN Healthcare, Inc. • AMN Healthcare Language Services, Inc. • AMN Leadership Solutions, Inc. • AMN Services, LLC • AMN Staffing Services, LLC • AMN Workforce Solutions, LLC • Avantas, LLC ...
IRS number
61500476
AMN stock data
Analyst ratings and price targets
Latest filings (excl ownership)
10-K
2022 FY
Annual report
22 Feb 23
8-K
Amn Healthcare Announces Fourth Quarter and Full Year 2022 Results
16 Feb 23
8-K
Amendments to Articles of Incorporation or Bylaws
16 Dec 22
10-Q
2022 Q3
Quarterly report
4 Nov 22
8-K
Amn Healthcare Announces Third Quarter 2022 Results
3 Nov 22
8-K
Departure of Directors or Certain Officers
31 Oct 22
10-Q
2022 Q2
Quarterly report
5 Aug 22
8-K
Amn Healthcare Announces Second Quarter 2022 Results
4 Aug 22
8-K
AMN Healthcare Services, Inc. Announces $250 Million Share Repurchase Program
15 Jun 22
8-K
Submission of Matters to a Vote of Security Holders
11 May 22
Transcripts
AMN
Earnings call transcript
2022 Q4
16 Feb 23
AMN
Earnings call transcript
2022 Q3
3 Nov 22
AMN
Earnings call transcript
2022 Q2
8 Aug 22
AMN
Earnings call transcript
2022 Q1
6 May 22
AMN
Earnings call transcript
2021 Q4
18 Feb 22
AMN
Earnings call transcript
2021 Q3
8 Nov 21
AMN
Earnings call transcript
2021 Q2
8 Aug 21
AMN
Earnings call transcript
2021 Q1
9 May 21
AMN
Earnings call transcript
2020 Q4
19 Feb 21
AMN
Earnings call transcript
2020 Q3
7 Nov 20
Latest ownership filings
4/A
Denise L Jackson
30 Mar 23
4
Denise L Jackson
30 Mar 23
4
Denise L Jackson
30 Mar 23
4/A
Mark Christopher Hagan
30 Mar 23
4/A
Jeffrey R Knudson
30 Mar 23
4
Mark Christopher Hagan
10 Mar 23
4/A
Denise L Jackson
27 Feb 23
4
Mark Christopher Hagan
17 Feb 23
4
Denise L Jackson
17 Feb 23
SC 13G/A
VANGUARD GROUP INC
9 Feb 23
Financial summary
| Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 137.87 mm | 137.87 mm | 137.87 mm | 137.87 mm | 137.87 mm | 137.87 mm |
| Cash burn (monthly) | 27.89 mm | 9.07 mm | (no burn) | (no burn) | (no burn) | (no burn) |
| Cash used (since last report) | 85.98 mm | 27.96 mm | n/a | n/a | n/a | n/a |
| Cash remaining | 51.90 mm | 109.91 mm | n/a | n/a | n/a | n/a |
| Runway (months of cash) | 1.9 | 12.1 | n/a | n/a | n/a | n/a |
Institutional ownership, Q4 2022
| 13F holders | Current |
|---|---|
| Total holders | 470 |
| Opened positions | 68 |
| Closed positions | 51 |
| Increased positions | 174 |
| Reduced positions | 171 |
| 13F shares | Current |
|---|---|
| Total value | 4.07 tn |
| Total shares | 41.66 mm |
| Total puts | 204.61 k |
| Total calls | 200.30 k |
| Total put/call ratio | 1.0 |
| Largest owners | Shares | Value |
|---|---|---|
| BLK Blackrock | 7.15 mm | $735.39 bn |
| Vanguard | 5.46 mm | $561.05 bn |
| STT State Street | 1.48 mm | $151.97 bn |
| Dimensional Fund Advisors | 1.25 mm | $128.42 bn |
| Point72 Asset Management | 902.00 k | $92.74 bn |
| BAC Bank Of America | 879.82 k | $90.46 bn |
| Fuller & Thaler Asset Management | 870.69 k | $89.51 bn |
| Geode Capital Management | 862.56 k | $88.68 bn |
| IVZ Invesco | 739.50 k | $76.03 bn |
| Renaissance Technologies | 678.00 k | $69.70 bn |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 9 Mar 23 | Mark Christopher Hagan | Common Stock | Payment of exercise | Dispose F | No | No | 88.47 | 1,291 | 114.21 k | 26,072 |
| 9 Mar 23 | Mark Christopher Hagan | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,603 | 0.00 | 27,363 |
| 15 Feb 23 | Jackson Denise L | Common Stock | Payment of exercise | Dispose F | No | No | 97.49 | 2,627 | 256.11 k | 23,253 |
| 15 Feb 23 | Jackson Denise L | Common Stock | Grant | Acquire A | No | No | 0 | 6,315 | 0.00 | 25,880 |
| 15 Feb 23 | Mark Christopher Hagan | Common Stock | Payment of exercise | Dispose F | No | No | 97.49 | 2,953 | 287.89 k | 24,760 |
| 15 Feb 23 | Mark Christopher Hagan | Common Stock | Grant | Acquire A | No | No | 0 | 6,031 | 0.00 | 27,713 |
| 15 Jan 23 | Jackson Denise L | Common Stock | Payment of exercise | Dispose F | No | No | 103.86 | 344 | 35.73 k | 19,565 |
| 15 Jan 23 | Jackson Denise L | Common Stock | Option exercise | Acquire M | No | No | 0 | 828 | 0.00 | 19,909 |
| 15 Jan 23 | Jackson Denise L | RSU Common Stock | Option exercise | Acquire M | No | No | 0 | 3,706 | 0.00 | 3,706 |
| 15 Jan 23 | Jackson Denise L | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 1,172 | 0.00 | 2,381 |
News
Stocks That Hit 52-Week Lows On Friday
24 Mar 23
5 Value Stocks In The Healthcare Sector
6 Mar 23
BMO Capital Maintains Outperform on AMN Healthcare Services, Lowers Price Target to $109
21 Feb 23
Credit Suisse Reiterates Outperform on AMN Healthcare Services, Maintains $147 Price Target
17 Feb 23
Baird Maintains Neutral on AMN Healthcare Services, Lowers Price Target to $111
17 Feb 23
Press releases
AMN Healthcare Announces Fourth Quarter and Full Year 2022 Results
16 Feb 23
AMN Healthcare Earns High Marks in Nation's Top Gender Equality Index
31 Jan 23
ShiftKey, Tech Company Leading Future of Work, Makes Strategic Executive Hires
24 Jan 23
AMN Healthcare to Hold Fourth Quarter and Full Year 2022 Earnings Conference Call on Thursday, February 16, 2023
17 Jan 23